Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip

NCT02683239 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5331

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis of the Knee or Hip

Interventions

DRUG: Fasinumab
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]